Markets

Insider Trading

Hedge Funds

Retirement

Opinion

7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds

Page 1 of 2

In this article, we will look at the best small-cap healthcare stocks to buy according to hedge funds. On February 16, Deloitte released its 2026 Global Health Care Outlook, and the findings, drawn from a survey of 180 C-suite executives across major global health systems, paint a picture of an industry under pressure but pushing forward.

The overarching message was that healthcare is undergoing a fundamental transformation, and the organizations that adapt fastest are the ones that will come out ahead. Financial performance is front and center, with over 70% of non-US health executives expecting operating revenues and margins to improve this year, with AI and digital tools playing a growing role in driving those gains.

The survey also revealed that the workforce remains the single biggest concern across the board, with more than 90% of global health leaders citing productivity improvement as a priority. At the same time, cybersecurity has quietly moved from a back-office issue to a boardroom conversation, with nearly half of non-US executives flagging it as a top concern for 2026. The firm highlighted that AI is generating plenty of excitement, but adoption is still in early stages, and health systems are under real pressure to show a return on their investments.

For investors, this is a sector navigating genuine complexity but also one with compelling long-term tailwinds. So, which healthcare stocks are worth watching right now? Let’s explore our 7 Best Small-Cap Healthcare Stocks to Buy According to Hedge Funds.

Yuganov Konstantin/Shutterstock.com

Our Methodology

To identify relevant stocks for this article, we screened U.S.-listed healthcare companies with market capitalizations between $300 million and $2 billion. Also, we only shortlisted stocks with at least 50% upside potential, according to consensus, as of the March 27 close.

Next, we identified the number of hedge funds that held positions in these stocks by the end of the fourth quarter of 2025. Finally, we selected 7 stocks with the highest number of hedge funds holding stakes and ranked them in ascending order.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

7. Inspire Medical Systems Inc. (NYSE:INSP)

Inspire Medical Systems Inc. (NYSE:INSP) is one of the 7 best small-cap healthcare stocks to buy according to hedge funds.

On March 16, Stifel maintained a Buy rating on Inspire Medical Systems Inc. (NYSE:INSP). The firm highlighted that CMS confirmed new HGNS C-codes will be assigned to the same APC 5465 as CPT 64582, keeping hospital facility fees broadly unchanged.

The firm noted that this removes a key downside risk related to reimbursement. However, it added that uncertainty still remains around physician fees and the potential impact of the -52 modifier, pending further guidance from regulators.

On February 27, KeyBanc reported that CMS announced the addition of six new HCPCS codes for the April Integrated Outpatient Code Editor, which will go into effect on January 1st, 2026. These included three codes that describe procedures for Inspire Medical Systems Inc. (NYSE:INSP).

The most recent MLN Connects Newsletter also mentioned the recent confusion regarding hypoglossal nerve stimulation reimbursement. The firm claims that, even though it is still early, this move is considered directionally positive because it may help clarify long-term and product-specific payment methods.

Inspire Medical Systems Inc. (NYSE:INSP) is engaged in developing and marketing treatments for obstructive sleep apnea (OSA). It provides neurostimulation technology for the secure treatment of mild to severe OSA conditions. The company also delivers closed-loop solutions and mild hypoglossal nerve stimulation to patients.

Page 1 of 2

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!